IL6R and respiratory failure: According to the results, the interleukin-6 receptor antagonists might be effective in patients with elevated values of interleukin-6 (but below 72 pg/mL), and before the clinical deterioration in terms of respiratory failure and need for mechanical ventilation, as positive results in terms of lower mortality rate among this subset of patients are still to be demonstrated [22].